Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_assertion type Assertion NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_head.
- NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_assertion description "[GEP NETs occur either sporadically or as part of endocrine tumor susceptibility syndromes such as multiple endocrine neoplasia type 1 (MEN1), von Hippel Lindau (VHL) syndrome, neurofibromatosis (NF-1), and possibly tuberous sclerosis (TSC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_provenance.
- NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_assertion evidence source_evidence_literature NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_provenance.
- NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_assertion SIO_000772 19125015 NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_provenance.
- NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_assertion wasDerivedFrom befree-20140225 NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_provenance.
- NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_assertion wasGeneratedBy ECO_0000203 NP892466.RAt9I2xCgFD8N_t-Ng9rITQbh7m0WwXKZwNN74qudYdDA130_provenance.